Vera Therapeutics VERA
NASDAQ VERA
$30.99 -1.30 (-4.03%)
At close: Oct 1, 2026 · 4:00 PM EDT

Vera Therapeutics (VERA) Non Operating Interest Expenses (2020 - 2026)

Updated

Vera Therapeutics (VERA) posted Non Operating Interest Expenses of $1.85 million for Q2 2026, down 1.4% from $1.87 million a year earlier but up 1.4% from the prior quarter.

Analysis

Vera Therapeutics (VERA) Non Operating Interest Expenses (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Interest Expenses at Vera Therapeutics was $7.54 million, up 0.8% year-over-year; for FY2025, it was $7.53 million, down 1.2% from FY2024.

  • Annual Non Operating Interest Expenses shows a five-year compound annual growth rate of 114.5% (FY2020 to FY2025).
  • In prior years, Vera Therapeutics' Non Operating Interest Expenses was $7.63 million in FY2024 (+101.4%), $3.79 million in FY2023 (+281.7%), $992,000 in FY2022 and $20,000 in FY2021 (-88.0%).
  • Quarterly Non Operating Interest Expenses has run from a low of $20,000 in Q4 2021 to a high of $1.96 million in Q3 2025 over five years.
  • On a year-over-year basis, Non Operating Interest Expenses increased in five of the last eight quarters, with growth averaging 22.2%.
  • The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q1 2023, with growth of 640.7%; the weakest was Q1 2025, with a decline of 6.0%.
  • According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $1.82 million (Q1 2026), $1.9 million (Q4 2025) and $1.96 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Vera Therapeutics 2.33 Bn 2.33 Bn - 1.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.85 Mn
Mar 31, 2026 1.82 Mn
Dec 31, 2025 1.90 Mn
Sep 30, 2025 1.96 Mn
Jun 30, 2025 1.87 Mn
Mar 31, 2025 1.79 Mn
Dec 31, 2024 1.87 Mn
Sep 30, 2024 1.94 Mn
Jun 30, 2024 1.91 Mn
Mar 31, 2024 1.91 Mn
Dec 31, 2023 1.06 Mn
Sep 30, 2023 943,000.00
Jun 30, 2023 914,000.00
Mar 31, 2023 874,000.00
Dec 31, 2022 599,000.00
Sep 30, 2022 147,000.00
Jun 30, 2022 128,000.00
Mar 31, 2022 118,000.00
Dec 31, 2021 20,000.00
Dec 31, 2020 15,000.00
API Access

Vera Therapeutics Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=VERA&period=max&api_key=YOUR_API_KEY